Advertisement
BOC vs HHS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOC is a Hold and HHS is a Hold.
BOC in upward trend: price rose above 50-day moving average on November 02, 2026
BOC moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend. In 33 of 51 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on BOC as a result. In 49 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 50%.
The Moving Average Convergence Divergence (MACD) for BOC just turned positive on October 23, 2026. Looking at past instances where BOC's MACD turned positive, the stock continued to rise in 24 of 45 cases over the following month. The odds of a continued upward trend are 53%.
The 10-day moving average for BOC crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 47%.
Following a +4.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where BOC advanced for three days, in 149 of 259 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
The Aroon Indicator entered an Uptrend today. In 82 of 130 cases where BOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.
Bearish Trend Analysis
The 10-day RSI Indicator for BOC moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In 13 of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 53 cases where BOC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BOC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
BOC broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.817) is normal, around the industry mean (-1.578). P/E Ratio (-32.405) is within average values for comparable stocks, (18.965). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (0.772). Dividend Yield (0.000) settles around the average of (674.816) among similar stocks. P/S Ratio (3.701) is also within normal values, averaging (2.059).
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. BOC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BOC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
HHS's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for HHS turned positive on November 09, 2026. Looking at past instances where HHS's MACD turned positive, the stock continued to rise in 38 of 52 cases over the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HHS's RSI Indicator exited the oversold zone, 18 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
Following a +2.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where HHS advanced for three days, in 181 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
HHS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 52 cases where HHS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HHS as a result. In 75 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
HHS moved below its 50-day moving average on October 20, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HHS crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HHS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for HHS entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.923) is normal, around the industry mean (-1.578). P/E Ratio (-5.143) is within average values for comparable stocks, (18.965). Projected Growth (PEG Ratio) (0.472) is also within normal values, averaging (0.772). Dividend Yield (0.859) settles around the average of (674.816) among similar stocks. P/S Ratio (0.219) is also within normal values, averaging (2.059).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. HHS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HHS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
BOC | HHS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 27 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 35 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 91 | 97 | |
PRICE GROWTH RATING 1..100 | 46 | 37 | |
P/E GROWTH RATING 1..100 | 98 | 94 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BOC's Valuation (5) in the Advertising Or Marketing Services industry is in the same range as HHS (35). This means that BOC’s stock grew similarly to HHS’s over the last 12 months.
BOC's Profit vs Risk Rating (100) in the Advertising Or Marketing Services industry is in the same range as HHS (100). This means that BOC’s stock grew similarly to HHS’s over the last 12 months.
BOC's SMR Rating (91) in the Advertising Or Marketing Services industry is in the same range as HHS (97). This means that BOC’s stock grew similarly to HHS’s over the last 12 months.
HHS's Price Growth Rating (37) in the Advertising Or Marketing Services industry is in the same range as BOC (46). This means that HHS’s stock grew similarly to BOC’s over the last 12 months.
HHS's P/E Growth Rating (94) in the Advertising Or Marketing Services industry is in the same range as BOC (98). This means that HHS’s stock grew similarly to BOC’s over the last 12 months.
| BOC | HHS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 76% | 2 days ago 62% |
| Stochastic ODDS (%) | 2 days ago 81% | 2 days ago 79% |
| Momentum ODDS (%) | 2 days ago 50% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 53% | 2 days ago 73% |
| TrendWeek ODDS (%) | 2 days ago 55% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 55% | 2 days ago 83% |
| Advances ODDS (%) | 8 days ago 58% | 9 days ago 72% |
| Declines ODDS (%) | 6 days ago 72% | 21 days ago 77% |
| BollingerBands ODDS (%) | 2 days ago 78% | 2 days ago 69% |
| Aroon ODDS (%) | 2 days ago 63% | 2 days ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BOC’s FA Score shows that 1 FA rating(s) are green while HHS’s FA Score has 0 green FA rating(s).
- BOC’s FA Score: 1 green, 4 red.
- HHS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BOC’s TA Score shows that 6 TA indicator(s) are bullish while HHS’s TA Score has 4 bullish TA indicator(s).
- BOC’s TA Score: 6 bullish, 4 bearish.
- HHS’s TA Score: 4 bullish, 6 bearish.
Price Growth
BOC (@Industrial Conglomerates) experienced а +0.29% price change this week, while HHS (@Industrial Conglomerates) price change was -0.50% for the same time period.
The average weekly price growth across all stocks in the @Industrial Conglomerates industry was +2.62%. For the same industry, the average monthly price growth was -0.36%, and the average quarterly price growth was -7.01%.
Reported Earning Dates
BOC is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Industrial Conglomerates (+2.62% weekly)Industrial Conglomerates specialize in numerous types of products, most of which comprise industrial goods, while some also go towards meeting household needs. Honeywell (makes engineering services and aerospace systems), United Technologies Corporation(manufactures aircraft engines, aerospace systems, HVAC, elevators and escalators, fire and security, building systems, and industrial products, among others), 3M (over 60,000 products under several world-renowned brands, including adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical & electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software and optical films).
Advertisement
BOC and
Correlation & Price change
A.I.dvisor indicates that over the last year, BOC has been loosely correlated with CMPR. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BOC jumps, then CMPR could also see price increases.
| Ticker / NAME | Correlation To BOC | 1D Price Change % | ||
|---|---|---|---|---|
| BOC | 100% | -0.58% | ||
| CMPR - BOC | 37% Loosely correlated | +2.37% | ||
| ZD - BOC | 36% Loosely correlated | +1.15% | ||
| STGW - BOC | 33% Loosely correlated | -1.91% | ||
| OMC - BOC | 33% Poorly correlated | +0.38% | ||
| EVC - BOC | 31% Poorly correlated | -2.04% | ||
More | ||||
HHS and
Correlation & Price change
A.I.dvisor tells us that HHS and WPP have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HHS and WPP's prices will move in lockstep.